Sir: James Warner & Robert Blizard (Psychiatric Bulletin, June 1998, 22, 342-344) provide an illuminating account of the torment to be experienced by the tiro seeking to turn booklet learning into clinical practice. At the same time they add to the literature from academic nonclinicians who seem to be determined to deny older people with dementia access to donepezil, and presumably other anticholinesterase inhibi tors.
Perhaps I could put Drs Warner & Blizard out of their misery and at the same time reassure their patient's wife and perhaps even their patient, that common sense or clinical sense still has a part to play in medical practice.
There is an accumulation of evidence that the anticholinesterase inhibitors improve cognitive function, reduce non-cognitive symptoms and improve activities of every day living, in a proportion of patients suffering from Alzheimer's disease. Not everyone obtains improvement and there may be flaws which the purist will find in both the design and presentation of studies. Nevertheless most people will understand that these compounds hold out the prospect that some patients will gain benefit from a medication where, hitherto, there has been no hope that any medicine would achieve benefit. What the pa tient's wife is asking is that her husband be given the opportunity to see whether donepezil will help him. Ifthe compound is tried and there is no change for the better she will be the first to agree with the clinician that there is no point in pressing on with the treatment. If, however, there is improvement or the arrest of a pattern of decline, both she and the clinician will be pleased, for this is not what their experience has led them to expect from the natural history of the disorder.
The clinical method is that, having reviewed the literature, weighing the possibility of benefit and the risk of adverse effects and explaining these to the patient and carer, the consultant who is familiar and confident in managing patients with this condition will prescribe the new treatment and monitor the outcomes.
Torment and headaches gone. Next patient please. Licence to export methylphenidate Colleagues who work with substance misusers are no doubt familiar with the regulations about carrying prescribed controlled drugs when tra velling abroad. A straw poll among child and adolescent psychiatrists suggested that child psychiatrists are not. As the prescribing of the controlled drug methylphenidate for hyperactMty becomes more common and the summer holiday period approaches, it seemed timely to seek clarifica tion. A telephone call to the Drugs Branch of the Home Office (at 50 Queen Anne's Gate, London SW1H 9AT, telephone 0171 273 3806) yielded the following information.
Controlled drugs may be taken out of the country (exported) and any unused portion reimported, without hindrance by HM Customs provided that certain documentation is carried. This documentation varies with the total quan tity of drug involved. For methylphenidate the cut-off quantity is 900 mg, which I note is equivalent to 15 days' supply at maximum British National Formulary dosage.
Below this quantity patients should carry a letter from the prescribing doctor confirming they have been prescribed the medication and the quantity they will be carrying. Above this quantity patients are required to obtain a licence to export. This requires that the prescribing doctor writes, on the patient's behalf, to the Home Office stating the full name and address of the patient, the country they intend to visit, with departure and return dates, the name of the drug, its form and strength (e.g. methylpheni date, tablets, 5 mg) and the total quantity in words and figures that they will be exporting.
The Home Office generally requires at least a week's notice to issue the licence. Patients should also be made aware that this documenta tion allows only for the export and re-import of the controlled drug from and to the UK. The regulations regarding importing to destination countries vary and it is the responsibility of the traveller, not the Home Office or the prescribing doctor, to check with the embassy of the destination country. The Home Office Drugs Branch may, however, be aware of particular problems and be able to offer up-to-date in formation regarding these.
DAVID HAMER, Senior Registrar in Child and Adolescent
Psychiatry. Child and Family Therapy Services, Marsden Street. Chesterfield, Derbyshire S40 1JY
Psychiatric disorders in rural communities
Sir: We read with interest the editorial by GrÃ©goire & Thornicroft (Psychiatric Bulletin. May 1998, 22, 273-277) and the paper by Smith & Ramana in the same issue (Psychiatric Bulletin. May 1998, 22, 280-284) concerning psychiatric disorders in rural communities. We were, however, both perplexed and frustrated that two articles so obviously concerned with mental ill health were entitled "Rural mental health" and "Mental health in rural areas . . .", respectively. The use of euphemisms for mental illness appears to be a growth area in the psychiatric literature. "Mental health morbidity", the opening words of Smith & Ramana's ab stract, is a good example of the kind of selfcontradictory phraseology that can result. GrÃ©goire& Thornicroft do not demonstrate any similar reticence in the use of the term "physical disease". This is perhaps not surprising given that the characterisation of such as "physical health morbidity" would not only be unwieldy, but self evidently perverse. Similarly, the fact that there is a high incidence of psychiatric illness and suicide in male farmers is not, we would argue, best conceptualised as a 'mental health problem' any more than a cardiac arrest is most appropriately described as a 'physical health problem'.
We suggest that we would be better served as a profession by having the courage of our convic tions and being explicit with our patients in identifying significant 'mental health problems' for what they are -psychiatric illnesses (Roth & Kroll, 1986) . To do otherwise is to invite conceptual muddle for the sake of a misguided psychiatric political correctness. ROTH 
'Absconsion'
Sir: I first came across the word 'absconsion' about 12 years ago, when a colleague spoke of a patient as presenting a significant risk of 'absconsion'. Since then I have come to find that many mental health workers, especially in the forensic side of our work, believe that the word actually exists in the language.
But of course it does not. Abscond, absconder, absconded, absconding -yes; absconsion -no.
Fortunately, the English language is suffi ciently flexible to take on new words. 'Abscon sion' is so useful that we might as well officially adopt it. 
IKECHUKWU Ã"BLALO AZUONYE, Consultant

